CATALYST BIOSCIENCES, INC. (14)

Browse by Contract Category

Contracts

Form of Stock Option Award Agreement (Filed With SEC on March 4, 2021)
Second Amendment to Office Lease, dated July 17, 2020, by and between 611 Gateway Center, L.P. and Catalyst Biosciences, Inc (Filed With SEC on November 5, 2020)
Offer Letter by and between Clinton Musil and Catalyst Biosciences, Inc. dated June 9, 2020 (Filed With SEC on November 5, 2020)
Amended and Restated Collaboration Agreement, dated May 8, 2020, by and between Mosaic Biosciences, Inc. and Catalyst Biosciences, Inc (Filed With SEC on August 6, 2020)
Description of Annual Cash Incentive Program (Filed With SEC on February 20, 2020)
Amended and Restated License Agreement, dated December 13, 2018, by and between Catalyst and ISU Abxis (Filed With SEC on March 8, 2019)
Underwriting Agreement, dated January 26, 2021, by and between Catalyst Biosciences, Inc. and Piper Sandler & Co., as representative of the several Underwriters named therein (Filed With SEC on January 27, 2021)
Underwriting Agreement, dated June 18, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters named... (Filed With SEC on June 19, 2020)
Description of Securities (Filed With SEC on February 20, 2020)
Amended and Restated Collaboration Agreement, dated December 18, 2019, by and between Mosaic Biosciences, Inc. and Catalyst Biosciences, Inc (Filed With SEC on February 20, 2020)
License and Collaboration Agreement, dated December 18, 2019, by and between Biogen International GMBH and Catalyst Biosciences, Inc (Filed With SEC on February 20, 2020)
Underwriting Agreement, dated February 13, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters... (Filed With SEC on February 14, 2020)
Cooperation Agreement, effective as of January 13, 2020, between Catalyst Biosciences, Inc. and certain Investors specified therein (Filed With SEC on January 17, 2020)
Clinical Supply Agreement, effective as of October 4, 2019, by and between Catalyst Biosciences, Inc. and Catalent Indiana, LLC (Filed With SEC on October 15, 2019)